The FORCE Blog
Posts 309 to 322 of 358
March 01, 2014
Volunteer Spotlight - Susie Goldenberg
Posted in:
Volunteer Spotlight
Tags:
FORCE ,
Volunteer
January 01, 2014
Volunteer Spotlight - Marisol Rosas
Posted in:
Volunteer Spotlight
Tags:
FORCE ,
Volunteer
November 01, 2013
Volunteer Spotlight - Paul Kredow
Posted in:
Volunteer Spotlight
Tags:
FORCE ,
Volunteer
September 20, 2013
What is Pelvic Health Rehabilitation?
Posted in:
Risk Management ,
Quality Of Life
Tags:
Oophorectomy ,
Surgical Risk ,
Pelvic Health ,
Hysterectomy
September 17, 2013
Voices: Sisters Survivors for the Long Run
Posted in:
Supporting FORCE ,
Inspirational ,
Voices
Tags:
Fitness ,
Supporting Force
September 06, 2013
Challenges to Hereditary Cancer Research
Posted in:
Research
Tags:
Hereditary Cancer Research ,
Clinical Trials ,
Patient Engagement ,
Patient Centered Research
September 01, 2013
Volunteer Spotlight - Kate Downey Berges
Posted in:
Volunteer Spotlight
Tags:
FORCE ,
Volunteer
July 01, 2013
Volunteer Spotlight - Julie Klein
Posted in:
Volunteer Spotlight
Tags:
FORCE ,
Volunteer
May 01, 2013
Volunteer Spotlight - Rachel Householder
Posted in:
Volunteer Spotlight
Tags:
FORCE ,
Volunteer
March 01, 2013
Volunteer Spotlight - Amy Byer Shainman
Posted in:
Volunteer Spotlight
Tags:
FORCE ,
Volunteer
February 24, 2013
Hopeful Progress in Ovarian Cancer Prevention Research
Posted in:
Research
Tags:
BRCA ,
Cancer Prevention ,
Hereditary Cancer Research ,
Ovarian Cancer ,
Genetic Testing ,
BRCA1 ,
BRCA2 ,
Prophylactic Surgery ,
Ovarian Cancer Early Detection ,
Screening And Prevention
January 17, 2013
Drawing Attention To High-risk Screening
Posted in:
Risk Management ,
Guidelines
Tags:
BRCA ,
Breast Cancer ,
Cancer Prevention ,
Hereditary Cancer Research ,
Prophylactic Mastectomy ,
BRCA1 ,
BRCA2 ,
Previvor ,
Prophylactic Surgery ,
Survivor ,
Ovarian Cancer Early Detection ,
HBOC ,
USPSTF ,
Screening And Prevention
January 01, 2013
Volunteer Spotlight - Tara Freundlich
Posted in:
Volunteer Spotlight
Tags:
FORCE ,
Volunteer
December 12, 2012
Clinical Trials for Hereditary Cancer: Where the Rubber Meets the Road
Posted in:
Research
Tags:
BRCA ,
Breast Cancer ,
Hereditary Cancer Research ,
BRCA1 ,
BRCA2 ,
FDA ,
Clinical Trials ,
PARP Inhibitor